Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
OncoTherapy Science, Inc.
Bayer
General Oncology, Inc.
OncoNano Medicine, Inc.
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Ono Pharmaceutical Co. Ltd
Lyell Immunopharma, Inc.
National Cancer Institute (NCI)
Leap Therapeutics, Inc.
Dana-Farber Cancer Institute
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Sun Pharma Advanced Research Company Limited
University of Louisville
Cellectar Biosciences, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pharmacyclics LLC.